SYRE
#1057
Spyre Therapeutics, Inc. - Common Stock
90.3 6 USD
-0.03%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-3.48%
Changement Mensuel
-8.04%
Evolution sur 6 mois
+121.20%
Changement Annuel
+277.92%
Clôture Précédente
93.6 2
Open
90.3 6
Low
90.3 6
High
90.3 6
Volume
241
Financials
- Market Capitalization 7.97 B
- Employee 112
- Founded 2013
- CEO N/A
- Website www.spyre.com
- Headquarter Delaware, United States
- FIGI BBG0067L94B2
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-16.55
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1024 |  APGE Apogee Therapeutics, Inc. - Common Stock | 134.97 USD | +0.01% | +0.13% | +0.54% | +151.86% | 8.40 B USD | ||
| 1040 |  TGTX TG Therapeutics, Inc. - Common Stock | 53.93 USD | -3.21% | +1.39% | +0.88% | +83.62% | 8.26 B USD | ||
| 1090 |  RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 107.17 USD | -4.76% | -4.56% | +1.60% | -2.85% | 7.38 B USD | ||
| 1118 |  SRRK Scholar Rock Holding Corporation - Common Stock | 57.80 USD | -2.46% | +1.76% | +17.53% | +92.54% | 7.04 B USD |